James V. Mazzo
Share |
James V. Mazzo

Global President Ophthalmic Devices for Carl Zeiss Meditech AG 

James V. (Jim) Mazzo was recently appointed Global President of Carl Zeiss Meditec's Strategic Business Unit Ophthalmic Devices, which now includes three strategic business groups: Ophthalmic Diagnostics, Surgical Ophthalmology and Refractive Lasers. Mazzo is as well head of the company’s U.S. Sales and Service Center. Carl Zeiss Meditec has the broadest line of diagnostic and surgical products in the industry and has been an innovative leader for over 100 years.

Mazzo is one of the ophthalmic industry's best known and most respected business leaders with over 36 years of proven experience. His global reputation for building and running world-class organizations is based on 22 years leading and expanding Allergan's North American and European eye care organizations; 7 years as Chairman, President and CEO of Advanced Medical Optics (AMO) which was sold to Abbott Labs for $2.8 billion; 4 years as EVP of Abbott's global ophthalmology business; and 3 years as Executive Chairman and CEO of AcuFocus and Executive Chairman of Neurotech.

His accomplishments and contributions to the healthcare industry and business and educational communities include serving as Board Chairman of AdvaMed, a director of public corporations, and a trustee/advisor to universities.

 

Business History:

2013 - 2016: Mazzo's positions included Executive Chairman & Chief Executive Officer of AcuFocus, and Executive Chairman of Neurotech Pharmaceuticals.

As Executive Chairman and CEO, he successfully led AcuFocus which specializes in presbyopia correction and is known for its revolutionary KAMRA inlay. Widely accepted as the global leader in its category, the company's groundbreaking small aperture inlay has the widest range of regulatory approvals, and surgeon and patient adoption.

As Executive Chairman for Neurotech Pharmaceuticals, a biotechnology company, Mazzo oversaw the organization's development of sight-saving therapies for retinal diseases.

2009 - 2013: Mazzo was Executive Vice President of Abbott Laboratories, and President of Abbott Medical Optics (AMO) following the company's February 2009 acquisition of Advanced Medical Optics. Abbott [NYSE:ABT], is a global, broad-based healthcare company and leader in advanced refractive technologies for eye care professionals and patients. Headquartered in Santa Ana, California, AMO offers market leading technologies and services designed to address vision disorders at all stages of life.

2002 – 2009: Mazzo served as Chairman and CEO of Advanced Medical Optics, Inc., a position he assumed following the company's 2002 spin-off from Allergan which he led. While CEO of Advanced Medical Optics, an independent and publicly owned corporation, the company's sales rose from $540 million in 2002 to more than $1 billion in 2009, and increased its market cap from $430 million to $1.5 billion. During this time, he engineered several strategic acquisitions worth more than $3 billion, taking the company to a clear leadership position in the cataract and eye care markets, and the global No. 1 position in refractive surgery. Abbott Labs bought the Company in 2009.

1980 - 2002: Mazzo progressed throughout his 22-year career at Allergan, holding a variety of Senior Executive-level positions. He spent approximately 12 years living and working outside the United States, as President of Allergan’s Europe/Africa/Middle East region, Vice President and Managing Director (Italy), and Director of Marketing (Canada).

Related Activities: Mazzo held the position of Board Chairman,  AdvaMed (2010-2012) , the world's largest medical devices association. During his tenure as chair, he spearheaded the organization's efforts to advocate for legal, regulatory and economic environments that advanced global health care. These improvements enhanced patient access to life-changing medical technology.

Mazzo is a strong believer in education and serves on the University of California at Irvine (UCI) foundation (past Chairman). He is a trustee for Chapman University, a past trustee for University of San Diego and has mentored several exceptional undergraduate and graduate students in the ophthalmic field.

Additionally, he is Chairman of Neurotech, and is on the board of OCTANe, RPS, a diagnostic testing platform, and lantech, a provider of micro systems for treating cataracts. Mazzo is on the ASCRS Governing Board, the AAO Foundation Advisory Board and WOC Advisory Board. He is a member of the International Intraocular Implant Club (lllC), is Leerink’s Special Advisor Medical Devices and is Executive Committee Board Member with the Medical Device Manufacturers Association (MDMA). Mazzo is a former director of Microsemi Corporation.

Jim Mazzo has been married to Kelly for 35 years and they have two children, Nicki Mazzo Bennett, PhD, married with one child, and Chris Mazzo married and Sales Director of The Good Life Wine Collection. Jim is a graduate of California State University, Long Beach with a Bachelor of Science degree in Zoology.